221 related articles for article (PubMed ID: 28291391)
1. Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results.
Willmann JK; Bonomo L; Testa AC; Rinaldi P; Rindi G; Valluru KS; Petrone G; Martini M; Lutz AM; Gambhir SS
J Clin Oncol; 2017 Jul; 35(19):2133-2140. PubMed ID: 28291391
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Ultrasound Molecular Imaging in the Evaluation of Complex Ovarian Masses: A Practical Guide to Correlation with Ex Vivo Immunohistochemistry.
Antil N; Wang H; Kaffas AE; Desser TS; Folkins A; Longacre T; Berek J; Lutz AM
Adv Biol (Weinh); 2023 Aug; 7(8):e2300091. PubMed ID: 37403275
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
[TBL] [Abstract][Full Text] [Related]
6. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
[TBL] [Abstract][Full Text] [Related]
7. Improved Sensitivity in Ultrasound Molecular Imaging With Coherence-Based Beamforming.
Hyun D; Abou-Elkacem L; Perez VA; Chowdhury SM; Willmann JK; Dahl JJ
IEEE Trans Med Imaging; 2018 Jan; 37(1):241-250. PubMed ID: 29293430
[TBL] [Abstract][Full Text] [Related]
8. BR55 Ultrasound Molecular Imaging of Clear Cell Renal Cell Carcinoma Reflects Tumor Vascular Expression of VEGFR-2 in a Patient-Derived Xenograft Model.
Courcier J; Leguerney I; Benatsou B; Pochon S; Tardy I; Albiges L; Cournède PH; De La Taille A; Lassau N; Ingels A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003400
[TBL] [Abstract][Full Text] [Related]
9. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study.
Smeenge M; Tranquart F; Mannaerts CK; de Reijke TM; van de Vijver MJ; Laguna MP; Pochon S; de la Rosette JJMCH; Wijkstra H
Invest Radiol; 2017 Jul; 52(7):419-427. PubMed ID: 28257340
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Modeling of Targeted Ultrasound Contrast Agents for Quantitative Assessment of Anti-Angiogenic Therapy: a Longitudinal Case-Control Study in Colon Cancer.
Turco S; El Kaffas A; Zhou J; Lutz AM; Wijkstra H; Willmann JK; Mischi M
Mol Imaging Biol; 2019 Aug; 21(4):633-643. PubMed ID: 30225758
[TBL] [Abstract][Full Text] [Related]
11. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
12. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
[TBL] [Abstract][Full Text] [Related]
13. VEGFR2-Targeted Three-Dimensional Ultrasound Imaging Can Predict Responses to Antiangiogenic Therapy in Preclinical Models of Colon Cancer.
Zhou J; Wang H; Zhang H; Lutz AM; Tian L; Hristov D; Willmann JK
Cancer Res; 2016 Jul; 76(14):4081-9. PubMed ID: 27206846
[TBL] [Abstract][Full Text] [Related]
14. CAIX aptamer-functionalized targeted nanobubbles for ultrasound molecular imaging of various tumors.
Zhu L; Wang L; Liu Y; Xu D; Fang K; Guo Y
Int J Nanomedicine; 2018; 13():6481-6495. PubMed ID: 30410333
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles.
Wang J; Qin B; Chen X; Wagner WR; Villanueva FS
Mol Pharm; 2017 Mar; 14(3):781-790. PubMed ID: 28165246
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.
Bachawal SV; Jensen KC; Wilson KE; Tian L; Lutz AM; Willmann JK
Cancer Res; 2015 Jun; 75(12):2501-9. PubMed ID: 25899053
[TBL] [Abstract][Full Text] [Related]
17. Anatomical Road Mapping Using CT and MR Enterography for Ultrasound Molecular Imaging of Small Bowel Inflammation in Swine.
Wang H; Felt SA; Guracar I; Taviani V; Zhou J; Sigrist RMS; Zhang H; Liau J; Vilches-Moure JG; Tian L; Saenz Y; Bettinger T; Hargreaves BA; Lutz AM; Willmann JK
Eur Radiol; 2018 May; 28(5):2068-2076. PubMed ID: 29170798
[TBL] [Abstract][Full Text] [Related]
18. Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).
Pysz MA; Foygel K; Rosenberg J; Gambhir SS; Schneider M; Willmann JK
Radiology; 2010 Aug; 256(2):519-27. PubMed ID: 20515975
[TBL] [Abstract][Full Text] [Related]
19. Improved Detection of preclinical Colorectal Liver Metastases by High Resolution Ultrasound including Molecular Ultrasound Imaging using the targeted Contrast Agent BR55.
Hackl C; Schacherer D; Anders M; Wiedemann LM; Mohr A; Schlitt HJ; Stroszczynski C; Tranquart F; Jung EM
Ultraschall Med; 2016 Jun; 37(3):290-6. PubMed ID: 27112624
[TBL] [Abstract][Full Text] [Related]
20. [Research Progress of Targeted Ultrasound Contrast Agent BR55].
Zhang XY; Lü K; Li JC; Jiang YX; Xiao MS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Feb; 44(1):118-122. PubMed ID: 35300773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
